Coriell Life Sciences Named Top Pharmacogenomics Company 2022
Coriell Life Sciences’ President & CEO, Scott Megill was recently interviewed by Pharma Tech Outlook.
Unlocking the power of pharmacogenomics (PGx), – the study of how genes affect a person’s response to drugs – Coriell Life Sciences (CLS) empowers healthcare providers, pharmacists, laboratories, and individuals to better understand the efficacy and safety of medications on a personalized level, paving the way for more effective medical care.
“Driven by our mission to empower a healthier world, we go beyond genetic testing to improve population health, reduce costs, and simplify decision-making,” says Scott Megill, President and CEO of Coriell Life Sciences.
Complete the form below to learn more about how our medication safety program can help your employees or health plan participants.